Research programme: small molecule sirtuin activators - CCM Biosciences
Latest Information Update: 06 Nov 2023
At a glance
- Originator CCM Biosciences
- Class Antidementias; Antiparkinsonians; Infertility therapies; Small molecules
- Mechanism of Action Sirtuin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease; Infertility; Parkinson's disease